[1] 张春宁, 林华明, 麦大海,等. 肝动脉化疗栓塞术治疗中晚期原发性肝癌及预后相关因素分析. 肝脏, 2018,23:229-231.
[2] Xiaohong C, Wenlv L, Zhonghua L, et al. Epidemiology and management of acute kidney injury in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization..Curr protein pept sc, 2017, 18:1218-1223.
[3] 中国抗癌协会肝癌专业委员会. 原发性肝癌规范化病理诊断方案专家共识. 中华医学杂志, 2011, 91:645-647.
[4] Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron clin pract, 2012, 120:179-184.
[5] Bruix J, Reig M, Sherman M. Evidence-based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.. Gastroenterology, 2016, 150:835-853.
[6] 周巍, 张立伟, 郝峻烽,等. 经导管动脉内化疗栓塞术后急性肾损伤影响因素与预后分析. 中华消化病与影像杂志(电子版), 2016, 6:18-24.
[7] 周春泽, 侯昌龙, 王瑞峰,等. 肝功能Child A级肝癌患者肝动脉化疗栓塞术后并发急性肾损伤的危险因素分析. 中华放射学杂志, 2018, 52:213-217.
[8] Lee B C, Liu K L, Lin C L, et al. Risk of acute kidney injury after transarterial chemoembolisation in hepatocellular carcinoma patients: A nationwide population-based cohort study.. Eur radiol, 2017, 27:1-8.
[9] 王雨, 林志健, 张冰. 高尿酸血症大鼠的肠道尿酸排泄研究. 北京中医药大学学报,2018, 41:110-117. |
